Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

NCT07199335 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

HIV
Substance Use Disorder (SUD)
Injection Drug Use

Interventions

DRUG: APRETUDE (cabotegravir)

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]